Product
PRA023 IV
1 clinical trial
1 indication
Indication
HealthyClinical trial
A Phase 1, Double-Blind, Placebo-Controlled, Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PRA023 in Healthy Caucasian and Japanese Adult VolunteersStatus: Completed, Estimated PCD: 2022-08-31